Yang G - Search Results

1

Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer.

Yuan S, Yu Y, Chao KS, Fu Z, Yin Y, Liu T, Chen S, Yang X, Yang G, Guo H, Yu J. Yuan S, et al. Among authors: yang g, yang x. J Nucl Med. 2006 Aug;47(8):1255-9. J Nucl Med. 2006. PMID: 16883002 Free article. Clinical Trial.

2

[FDG PET/CT versus PET alone for pre-surgical detection of lymph node metastasis in esophageal carcinoma].

Yuan SH, Yu JM, Yu YH, Fu Z, Guo HB, Liu TH, Yang XH, Yang GR, Li WW. Yuan SH, et al. Zhonghua Zhong Liu Za Zhi. 2007 Mar;29(3):221-4. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17649642 Chinese.

3

[Preliminary study of 18F-FDG PET-CT in defining lymph node radiation target volume for non-small-cell lung cancer patients].

Liu LP, Yu JM, Guo HB, Fu Z, Han AQ, Yang GR. Liu LP, et al. Zhonghua Zhong Liu Za Zhi. 2007 Jun;29(6):453-6. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17974282 Chinese.

4

[Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].

Hu M, Yu JM, Liu NB, Liu LP, Guo HB, Yang GR, Zhang PL, Xu XQ. Hu M, et al. Zhonghua Zhong Liu Za Zhi. 2008 Apr;30(4):306-9. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18788639 Chinese.

5

[Correlation between PET-CT 18FDG uptake in primary lesions and clinicopathological parameters in esophageal carcinoma patients].

Feng R, Li MH, Kong L, Shi F, Yang GR, Yu JM. Feng R, et al. Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):452-4. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19950557 Chinese.

6

Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non-small-cell lung cancer.

Yuan S, Meng X, Yu J, Mu D, Chao KS, Zhang J, Zhong W, Yu Y, Wang J, Sun X, Yang G, Wang Y. Yuan S, et al. Among authors: yang g. Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):727-34. doi: 10.1016/j.ijrobp.2006.08.057. Int J Radiat Oncol Biol Phys. 2007. PMID: 17293231

7

Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.

Guo H, Zhu H, Xi Y, Zhang B, Li L, Huang Y, Zhang J, Fu Z, Yang G, Yuan S, Yu J. Guo H, et al. Among authors: yang g. J Nucl Med. 2007 Aug;48(8):1251-8. doi: 10.2967/jnumed.106.036509. Epub 2007 Jul 13. J Nucl Med. 2007. PMID: 17631554 Free article.

8

PET-based biodistribution and radiation dosimetry of epidermal growth factor receptor-selective tracer 11C-PD153035 in humans.

Liu N, Li M, Li X, Meng X, Yang G, Zhao S, Yang Y, Ma L, Fu Z, Yu J. Liu N, et al. Among authors: yang g, yang y. J Nucl Med. 2009 Feb;50(2):303-8. doi: 10.2967/jnumed.108.056556. Epub 2009 Jan 21. J Nucl Med. 2009. PMID: 19164239 Free article.

9

Bone metastasis in patients with non-small cell lung cancer: the diagnostic role of F-18 FDG PET/CT.

Liu N, Ma L, Zhou W, Pang Q, Hu M, Shi F, Fu Z, Li M, Yang G, Yu J. Liu N, et al. Among authors: yang g. Eur J Radiol. 2010 Apr;74(1):231-5. doi: 10.1016/j.ejrad.2009.01.036. Epub 2009 Mar 13. Eur J Radiol. 2010. PMID: 19285820

10

Hypoxia imaging with 18F-fluoroerythronitroimidazole integrated PET/CT and immunohistochemical studies in non-small cell lung cancer.

Hu M, Xing L, Mu D, Yang W, Yang G, Kong L, Yu J. Hu M, et al. Among authors: yang w, yang g. Clin Nucl Med. 2013 Aug;38(8):591-6. doi: 10.1097/RLU.0b013e318279fd3d. Clin Nucl Med. 2013. PMID: 23797219 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,622 results

Search Page

Filters